Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate Levels

Introduction. Gum Arabic (GA) is a complex polysaccharide with proven prebiotic properties and potentially beneficial systemic effects. Methods. We randomly allocated 36 chronic kidney disease (CKD) patients to receive 10, 20, or 40 grams daily of GA for four weeks and studied the systemic effects o...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarra Elamin, Mariam J. Alkhawaja, Amina Y. Bukhamsin, Mohamed A. S. Idris, Muntasir M. Abdelrahman, Nasrulla K. Abutaleb, Abdulrahman A. Housawi
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2017/9501470
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563835486076928
author Sarra Elamin
Mariam J. Alkhawaja
Amina Y. Bukhamsin
Mohamed A. S. Idris
Muntasir M. Abdelrahman
Nasrulla K. Abutaleb
Abdulrahman A. Housawi
author_facet Sarra Elamin
Mariam J. Alkhawaja
Amina Y. Bukhamsin
Mohamed A. S. Idris
Muntasir M. Abdelrahman
Nasrulla K. Abutaleb
Abdulrahman A. Housawi
author_sort Sarra Elamin
collection DOAJ
description Introduction. Gum Arabic (GA) is a complex polysaccharide with proven prebiotic properties and potentially beneficial systemic effects. Methods. We randomly allocated 36 chronic kidney disease (CKD) patients to receive 10, 20, or 40 grams daily of GA for four weeks and studied the systemic effects of this intervention. Results. Thirty participants completed the study with baseline glomerular filtration rate 29.1±9.9 mL/min/1.7 m2. In contrast to previous observations, we found no effect on serum urea or creatinine levels. GA supplementation was associated with a small but statistically significant drop in serum sodium level (138±2 to 136±3 mmol/L, p = 0.002) without affecting other electrolytes, urine volume, or indoxyl sulfate (IS) levels. GA supplementation was also associated with a significant drop in C-reactive protein (CRP) level (3.5±1.5 to 2.8±1.6 ng/mL, p = 0.02) even in patients who received only 10 g/day (4.4±1.2 to 3.2±1.5 ng/mL, p = 0.03). Conclusions. Supplementing the diet of CKD patients with 10–40 g/day of GA significantly reduced CRP level which could have a positive impact on these patients’ morbidity and mortality. This trial is registered with Saudi Clinical Trial Registry number 15011402.
format Article
id doaj-art-342c8aa01ab14fd987c4ef141df76370
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-342c8aa01ab14fd987c4ef141df763702025-02-03T01:12:21ZengWileyInternational Journal of Nephrology2090-214X2090-21582017-01-01201710.1155/2017/95014709501470Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate LevelsSarra Elamin0Mariam J. Alkhawaja1Amina Y. Bukhamsin2Mohamed A. S. Idris3Muntasir M. Abdelrahman4Nasrulla K. Abutaleb5Abdulrahman A. Housawi6King Fahad Specialist Hospital, Dammam 31444, Saudi ArabiaKing Fahad Specialist Hospital, Dammam 31444, Saudi ArabiaKing Fahad Specialist Hospital, Dammam 31444, Saudi ArabiaKing Fahad Specialist Hospital, Dammam 31444, Saudi ArabiaKing Fahad Specialist Hospital, Dammam 31444, Saudi ArabiaKing Fahad Specialist Hospital, Dammam 31444, Saudi ArabiaKing Fahad Specialist Hospital, Dammam 31444, Saudi ArabiaIntroduction. Gum Arabic (GA) is a complex polysaccharide with proven prebiotic properties and potentially beneficial systemic effects. Methods. We randomly allocated 36 chronic kidney disease (CKD) patients to receive 10, 20, or 40 grams daily of GA for four weeks and studied the systemic effects of this intervention. Results. Thirty participants completed the study with baseline glomerular filtration rate 29.1±9.9 mL/min/1.7 m2. In contrast to previous observations, we found no effect on serum urea or creatinine levels. GA supplementation was associated with a small but statistically significant drop in serum sodium level (138±2 to 136±3 mmol/L, p = 0.002) without affecting other electrolytes, urine volume, or indoxyl sulfate (IS) levels. GA supplementation was also associated with a significant drop in C-reactive protein (CRP) level (3.5±1.5 to 2.8±1.6 ng/mL, p = 0.02) even in patients who received only 10 g/day (4.4±1.2 to 3.2±1.5 ng/mL, p = 0.03). Conclusions. Supplementing the diet of CKD patients with 10–40 g/day of GA significantly reduced CRP level which could have a positive impact on these patients’ morbidity and mortality. This trial is registered with Saudi Clinical Trial Registry number 15011402.http://dx.doi.org/10.1155/2017/9501470
spellingShingle Sarra Elamin
Mariam J. Alkhawaja
Amina Y. Bukhamsin
Mohamed A. S. Idris
Muntasir M. Abdelrahman
Nasrulla K. Abutaleb
Abdulrahman A. Housawi
Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate Levels
International Journal of Nephrology
title Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate Levels
title_full Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate Levels
title_fullStr Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate Levels
title_full_unstemmed Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate Levels
title_short Gum Arabic Reduces C-Reactive Protein in Chronic Kidney Disease Patients without Affecting Urea or Indoxyl Sulfate Levels
title_sort gum arabic reduces c reactive protein in chronic kidney disease patients without affecting urea or indoxyl sulfate levels
url http://dx.doi.org/10.1155/2017/9501470
work_keys_str_mv AT sarraelamin gumarabicreducescreactiveproteininchronickidneydiseasepatientswithoutaffectingureaorindoxylsulfatelevels
AT mariamjalkhawaja gumarabicreducescreactiveproteininchronickidneydiseasepatientswithoutaffectingureaorindoxylsulfatelevels
AT aminaybukhamsin gumarabicreducescreactiveproteininchronickidneydiseasepatientswithoutaffectingureaorindoxylsulfatelevels
AT mohamedasidris gumarabicreducescreactiveproteininchronickidneydiseasepatientswithoutaffectingureaorindoxylsulfatelevels
AT muntasirmabdelrahman gumarabicreducescreactiveproteininchronickidneydiseasepatientswithoutaffectingureaorindoxylsulfatelevels
AT nasrullakabutaleb gumarabicreducescreactiveproteininchronickidneydiseasepatientswithoutaffectingureaorindoxylsulfatelevels
AT abdulrahmanahousawi gumarabicreducescreactiveproteininchronickidneydiseasepatientswithoutaffectingureaorindoxylsulfatelevels